Laddar...
Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”?
Over the past two decades, a considerable amount of oncolytic vector families has entered numerous clinical trials. However, to this date, the field has not yet been able to come to a common understanding regarding the best possible ways to administer oncolytic viruses to cancer patients. This is ma...
Sparad:
| I publikationen: | Mol Ther Oncolytics |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782955/ https://ncbi.nlm.nih.gov/pubmed/27119110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.18 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|